Home

BRYAN E ROBERTS

CIK 1239242 · last filed 2023-06-16

BRYAN E ROBERTS is a corporate insider who has filed 94 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for TXG, was dated Jun 16, 2023. Across all open-market trades the lifetime net is −$223.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $167.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$167.92M

Companies

9

Total Filings

94

Lifetime Open-Market Net

-$223.70M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TXG Director 3,878,925 $43.22 $167.65M -$218.40M 13 2023-06-16
CASTLIGHT HEALTH, INC. (CSLT) Delisted Director 0 $2.05 $0 $4.79M 16 2022-02-18
Achaogen, Inc. (AKAO) Delisted Director 637,675 — — $0 6 2018-06-07
Vitae Pharmaceuticals, Inc (VTAE) Delisted Director 275,450 — — $6.18M 4 2016-05-27
Zeltiq Aesthetics Inc (ZLTQ) Delisted Director 5,786 — — -$3.05M 11 2015-11-04
IRWD Director 71,951 $3.85 $277.0K -$13.16M 35 2015-06-16
ATHENAHEALTH INC (ATHN) Delisted Director 50 $9.59 $480 -$48.3K 5 2009-05-26
XENOPORT INC (XNPT) Delisted Director 20,279 — — -$2.9K 3 2007-06-01
SIRNA THERAPEUTICS INC (RNAI) Delisted Director 0 — — $0 1 2007-01-03

Recent Filings

94 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-16 TXG Grant (A) +1,865 $0 EDGAR
2023-05-19 TXG Conv (C) +3,790,422 $0 EDGAR
2022-06-17 TXG Grant (A) +2,120 $0 EDGAR
2022-02-18 CASTLIGHT HEALTH, INC. (CSLT) Delisted Disp (D) −5,660,448 $0 EDGAR
2021-06-15 TXG Grant (A) +625 $0 EDGAR
2021-06-14 CASTLIGHT HEALTH, INC. (CSLT) Delisted Grant (A) +70,707 $0 EDGAR
2021-05-04 TXG Conv (C) +2,000,000 $0 EDGAR
2020-12-10 TXG Mixed +2,093,487 $0 EDGAR
2020-09-18 TXG Other (J) −1,128,196 $0 EDGAR
2020-06-17 TXG Grant (A) — $0 EDGAR
Showing 1–10 of 94
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.